Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 171

1.

Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial.

O Byrne PM, Woodcock A, Bleecker ER, Bateman ED, Lötvall J, Forth R, Medley H, Jacques L, Busse WW.

Respir Res. 2014 Aug 11;15(1):88. [Epub ahead of print]

PMID:
25108545
[PubMed - as supplied by publisher]
Free Article
2.

Efficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised study.

Woodcock A, Lötvall J, Busse WW, Bateman ED, Stone S, Ellsworth A, Jacques L.

BMC Pulm Med. 2014 Jul 9;14(1):113. doi: 10.1186/1471-2466-14-113.

PMID:
25007865
[PubMed - in process]
Free PMC Article
3.

Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.

Koegelenberg CF, Noor F, Bateman ED, van Zyl-Smit RN, Bruning A, O'Brien JA, Smith C, Abdool-Gaffar MS, Emanuel S, Esterhuizen TM, Irusen EM.

JAMA. 2014 Jul;312(2):155-61. doi: 10.1001/jama.2014.7195.

PMID:
25005652
[PubMed - indexed for MEDLINE]
4.

Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists.

Willson J, Bateman ED, Pavord I, Lloyd A, Krivasi T, Esser D.

Appl Health Econ Health Policy. 2014 Aug;12(4):447-59. doi: 10.1007/s40258-014-0107-8.

PMID:
24974107
[PubMed - in process]
5.

Comparison of vilanterol, a novel long-acting beta2 agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroids.

Lötvall J, Bateman ED, Busse WW, O'Byrne PM, Woodcock A, Toler WT, Jacques L, Goldfrad C, Bleecker ER.

J Negat Results Biomed. 2014 Jun 13;13(1):9. doi: 10.1186/1477-5751-13-9.

PMID:
24928338
[PubMed - in process]
Free PMC Article
6.

Integrated care pathways for airway diseases (AIRWAYS-ICPs).

Bousquet J, Addis A, Adcock I, Agache I, Agusti A, Alonso A, Annesi-Maesano I, Anto JM, Bachert C, Baena-Cagnani CE, Bai C, Baigenzhin A, Barbara C, Barnes PJ, Bateman ED, Beck L, Bedbrook A, Bel EH, Benezet O, Bennoor KS, Benson M, Bernabeu-Wittel M, Bewick M, Bindslev-Jensen C, Blain H, Blasi F, Bonini M, Bonini S, Boulet LP, Bourdin A, Bourret R, Bousquet PJ, Brightling CE, Briggs A, Brozek J, Buhl R, Bush A, Caimmi D, Calderon M, Calverley P, Camargos PA, Camuzat T, Canonica GW, Carlsen KH, Casale TB, Cazzola M, Cepeda Sarabia AM, Cesario A, Chen YZ, Chkhartishvili E, Chavannes NH, Chiron R, Chuchalin A, Chung KF, Cox L, Crooks G, Crooks MG, Cruz AA, Custovic A, Dahl R, Dahlen SE, De Blay F, Dedeu T, Deleanu D, Demoly P, Devillier P, Didier A, Dinh-Xuan AT, Djukanovic R, Dokic D, Douagui H, Dubakiene R, Eglin S, Elliot F, Emuzyte R, Fabbri L, Fink Wagner A, Fletcher M, Fokkens WJ, Fonseca J, Franco A, Frith P, Furber A, Gaga M, Garcés J, Garcia-Aymerich J, Gamkrelidze A, Gonzales-Diaz S, Gouzi F, Guzmán MA, Haahtela T, Harrison D, Hayot M, Heaney LG, Heinrich J, Hellings PW, Hooper J, Humbert M, Hyland M, Iaccarino G, Jakovenko D, Jardim JR, Jeandel C, Jenkins C, Johnston SL, Jonquet O, Joos G, Jung KS, Kalayci O, Karunanithi S, Keil T, Khaltaev N, Kolek V, Kowalski ML, Kull I, Kuna P, Kvedariene V, Le LT, Lodrup Carlsen KC, Louis R, MacNee W, Mair A, Majer I, Manning P, de Manuel Keenoy E, Masjedi MR, Melen E, Melo-Gomes E, Menzies-Gow A, Mercier G, Mercier J, Michel JP, Miculinic N, Mihaltan F, Milenkovic B, Molimard M, Momas I, Montilla-Santana A, Morais-Almeida M, Morgan M, N'Diaye M, Nafti S, Nekam K, Neou A, Nicod L, O'Hehir R, Ohta K, Paggiaro P, Palkonen S, Palmer S, Papadopoulos NG, Papi A, Passalacqua G, Pavord I, Pigearias B, Plavec D, Postma DS, Price D, Rabe KF, Radier Pontal F, Redon J, Rennard S, Roberts J, Robine JM, Roca J, Roche N, Rodenas F, Roggeri A, Rolland C, Rosado-Pinto J, Ryan D, Samolinski B, Sanchez-Borges M, Schünemann HJ, Sheikh A, Shields M, Siafakas N, Sibille Y, Similowski T, Small I, Sola-Morales O, Sooronbaev T, Stelmach R, Sterk PJ, Stiris T, Sud P, Tellier V, To T, Todo-Bom A, Triggiani M, Valenta R, Valero AL, Valiulis A, Valovirta E, Van Ganse E, Vandenplas O, Vasankari T, Vestbo J, Vezzani G, Viegi G, Visier L, Vogelmeier C, Vontetsianos T, Wagstaff R, Wahn U, Wallaert B, Whalley B, Wickman M, Williams DM, Wilson N, Yawn BP, Yiallouros PK, Yorgancioglu A, Yusuf OM, Zar HJ, Zhong N, Zidarn M, Zuberbier T.

Eur Respir J. 2014 Aug;44(2):304-23. doi: 10.1183/09031936.00014614. Epub 2014 Jun 12. No abstract available.

PMID:
24925919
[PubMed - in process]
7.

Recent advances in COPD disease management with fixed-dose long-acting combination therapies.

Bateman ED, Mahler DA, Vogelmeier CF, Wedzicha JA, Patalano F, Banerji D.

Expert Rev Respir Med. 2014 Jun;8(3):357-79. doi: 10.1586/17476348.2014.910457. Epub 2014 May 7.

PMID:
24802656
[PubMed - in process]
8.

Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort.

Jones RC, Price D, Ryan D, Sims EJ, von Ziegenweidt J, Mascarenhas L, Burden A, Halpin DM, Winter R, Hill S, Kearney M, Holton K, Moger A, Freeman D, Chisholm A, Bateman ED; Respiratory Effectiveness Group.

Lancet Respir Med. 2014 Apr;2(4):267-76. doi: 10.1016/S2213-2600(14)70008-6. Epub 2014 Feb 13.

PMID:
24717623
[PubMed - in process]
Free Article
9.

The Global Alliance against Respiratory Diseases (GARD) Country Report.

Yorgancioglu A, Cruz AA, Bousquet J, Khaltaev N, Mendis S, Chuchalin A, Bateman ED, Camargos P, Chavannes NH, Bai C, Deleanu D, Kolek V, Kuna P, Laurendi G, Masjedi MR, Mele S, Mihaltan F, Pinto JR, Samolinski B, Scalera G, Sooronbaev T, Tageldin MA, Tuyetlan le T, Yusuf O, Akdis C, Baigenzhin A, Cagnani CB, Fletcher M, Gemicioglu B, Muhammed Y, Sagra H, To T, Wagner AH.

Prim Care Respir J. 2014 Mar;23(1):98-101. doi: 10.4104/pcrj.2014.00014. No abstract available.

PMID:
24570081
[PubMed - in process]
Free Article
10.

Complementing the randomized controlled trial evidence base. Evolution not revolution.

Price D, Bateman ED, Chisholm A, Papadopoulos NG, Bosnic-Anticevich S, Pizzichini E, Hillyer EV, Buist AS.

Ann Am Thorac Soc. 2014 Feb;11 Suppl 2:S92-8. doi: 10.1513/AnnalsATS.201308-276RM.

PMID:
24559027
[PubMed - in process]
11.

Integrating real-life studies in the global therapeutic research framework.

Roche N, Reddel HK, Agusti A, Bateman ED, Krishnan JA, Martin RJ, Papi A, Postma D, Thomas M, Brusselle G, Israel E, Rand C, Chisholm A, Price D; Respiratory Effectiveness Group.

Lancet Respir Med. 2013 Dec;1(10):e29-30. doi: 10.1016/S2213-2600(13)70199-1. Epub 2013 Dec 2. No abstract available.

PMID:
24461762
[PubMed - in process]
12.

A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 study.

Chapman KR, Beeh KM, Beier J, Bateman ED, D'Urzo A, Nutbrown R, Henley M, Chen H, Overend T, D'Andrea P.

BMC Pulm Med. 2014 Jan 17;14:4. doi: 10.1186/1471-2466-14-4.

PMID:
24438744
[PubMed - in process]
Free PMC Article
13.

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.

Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, Adcock IM, Bateman ED, Bel EH, Bleecker ER, Boulet LP, Brightling C, Chanez P, Dahlen SE, Djukanovic R, Frey U, Gaga M, Gibson P, Hamid Q, Jajour NN, Mauad T, Sorkness RL, Teague WG.

Eur Respir J. 2014 Feb;43(2):343-73. doi: 10.1183/09031936.00202013. Epub 2013 Dec 12. Erratum in: Eur Respir J. 2014 Apr;43(4):1216. Dosage error in article text.

PMID:
24337046
[PubMed - in process]
14.

Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol-fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study.

Vogelmeier CF, Bateman ED, Pallante J, Alagappan VK, D'Andrea P, Chen H, Banerji D.

Lancet Respir Med. 2013 Mar;1(1):51-60. doi: 10.1016/S2213-2600(12)70052-8. Epub 2012 Dec 6. Erratum in: Lancet Respir Med. 2013 Apr;1(2):101.

PMID:
24321804
[PubMed - in process]
15.

Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: a 24-week placebo and active-controlled randomised trial.

Lötvall J, Bleecker ER, Busse WW, O'Byrne PM, Woodcock A, Kerwin EM, Stone S, Forth R, Jacques L, Bateman ED.

Respir Med. 2014 Jan;108(1):41-9. doi: 10.1016/j.rmed.2013.11.009. Epub 2013 Nov 19.

PMID:
24295556
[PubMed - in process]
Free Article
16.

Cigarette smoke impairs cytokine responses and BCG containment in alveolar macrophages.

van Zyl-Smit RN, Binder A, Meldau R, Semple PL, Evans A, Smith P, Bateman ED, Dheda K.

Thorax. 2014 Apr;69(4):363-70. doi: 10.1136/thoraxjnl-2013-204229. Epub 2013 Nov 28.

PMID:
24287167
[PubMed - indexed for MEDLINE]
17.

Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone.

Bateman ED, O'Byrne PM, Busse WW, Lötvall J, Bleecker ER, Andersen L, Jacques L, Frith L, Lim J, Woodcock A.

Thorax. 2014 Apr;69(4):312-9. doi: 10.1136/thoraxjnl-2013-203600. Epub 2013 Nov 19.

PMID:
24253831
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Comparing dynamic hyperinflation and associated dyspnea induced by metronome-paced tachypnea versus incremental exercise.

Calligaro GL, Raine RI, Bateman ME, Bateman ED, Cooper CB.

COPD. 2014 Feb;11(1):105-12. doi: 10.3109/15412555.2013.841669. Epub 2013 Oct 23.

PMID:
24152211
[PubMed - in process]
19.

Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma.

O'Byrne PM, Bleecker ER, Bateman ED, Busse WW, Woodcock A, Forth R, Toler WT, Jacques L, Lötvall J.

Eur Respir J. 2014 Mar;43(3):773-82. doi: 10.1183/09031936.00064513. Epub 2013 Oct 17.

PMID:
24136330
[PubMed - in process]
Free PMC Article
20.

Tiotropium Respimat increases the risk of mortality: con.

Bateman ED.

Eur Respir J. 2013 Sep;42(3):590-3. doi: 10.1183/09031936.00042213. No abstract available.

PMID:
24000252
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk